Drug firms unveil price cuts

Aid agencies welcome move to make life-saving drugs cheaper in the developing world, with caveats.

    A number of leading drug firms have announced plans to cut prices dramatically for life-saving drugs in the developing world.

    UK-based Glaxo Smithkline, says it will reduce the cost of its Rotarix vaccine by 67 per cent. It will now cost $5 to immunise a child against rotavirus, a leading cause of diarrhoea.

    The price cuts have been broadly welcomed by aid agencies. But Save the Children says it only goes partly in plugging a $3.7bn shortfall needed to produce life-saving drugs.

    Al Jazeera spoke to Paul Cook, the head of advocacy at Tearfund.

    SOURCE: Al Jazeera


    YOU MIGHT ALSO LIKE

    How Moscow lost Riyadh in 1938

    How Moscow lost Riyadh in 1938

    Russian-Saudi relations could be very different today, if Stalin hadn't killed the Soviet ambassador to Saudi Arabia.

    Interactive: Coding like a girl

    Interactive: Coding like a girl

    What obstacles do young women in technology have to overcome to achieve their dreams? Play this retro game to find out.

    The War in October: What Happened in 1973?

    The War in October: What Happened in 1973?

    Al Jazeera examines three weeks of war from which both Arabs and Israelis claimed to emerge victorious.